HYFT
MINDWALK HLDG (HYFT)
NASDAQ
$1.80-$0.005 (-0.28%)
Price as of Jun 03, 2026 7:55 PM EDT
  • $82.2M
    Market Cap
  • N/A
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
04/30/2025
04/30/2024
04/30/2023
04/30/2022
Income Statement
Total Operating Revenue
24.5M
+0.008%
24.5M
+18.65%
20.7M
+6.72%
19.4M
+8.11%
Cost of Revenue
11.0M
-11.98%
12.5M
+36.95%
9.1M
+8.60%
8.4M
+31.49%
Gross Profit
13.5M
+12.40%
12.1M
+4.24%
11.6M
+5.28%
11.0M
-4.81%
Sales and Marketing Expense
4.3M
+21.31%
3.5M
-1.80%
3.6M
+387.57%
740,000
+7.09%
Research and Development Expense
-4.9M
+22.26%
-4.0M
-67.08%
-12.3M
+83.48%
-6.7M
+239.06%
Depreciation and Amortization Expense
5.1M
-10.74%
5.7M
-14.21%
6.7M
+77.37%
3.8M
+1.51%
Total Operating Expenses
14.7M
-5.50%
15.6M
-21.30%
19.8M
+1,600.60%
1.2M
-19.27%
Operating Profit
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-30.2M
+11.25%
-27.2M
+2.32%
-26.6M
+58.96%
-16.7M
+127.64%
Income Taxes
-4.0M
+164.29%
-1.5M
+28.02%
-1.2M
-238.44%
861,000
-35.99%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-30.2M
+11.25%
-27.2M
+2.32%
-26.6M
+58.96%
-16.7M
+127.64%
Net Income from Continuing Operations Applicable to Common
-30.2M
+11.25%
-27.2M
+2.32%
-26.6M
+58.96%
-16.7M
+127.64%
Basic EPS and Net Income
-0.91
-14.15%
-1.06
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
-0.91
-14.15%
-1.06
N/A
N/A
N/A
N/A
N/A
Basic Weighted Average Shares
33.4M
+30.23%
25.6M
+2.97%
24.9M
+26.46%
19.7M
+19.51%
Diluted Weighted Average Shares
33.4M
+30.23%
25.6M
+2.97%
24.9M
+26.46%
19.7M
+19.51%
Balance Sheet
Cash and Cash Equivalents
10.7M
+208.33%
3.5M
-58.22%
8.3M
-72.37%
30.0M
-28.24%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
10.7M
+208.33%
3.5M
-58.22%
8.3M
-72.37%
30.0M
-28.24%
Total Current Assets
18.8M
+63.26%
11.5M
-31.59%
16.8M
-55.19%
37.5M
-23.31%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
15.8M
-5.59%
16.7M
+60.66%
10.4M
+211.32%
3.3M
-17.05%
Total Long-Term Assets
80,000
-99.84%
48.5M
-20.52%
61.0M
+8.92%
56.0M
+209.51%
Total Assets
44.4M
-25.92%
60.0M
-22.91%
77.8M
-16.77%
93.5M
+39.63%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
9.0M
+10.93%
8.1M
+37.23%
5.9M
-36.09%
9.3M
+52.55%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
20.8M
-20.15%
26.1M
+30.27%
20.0M
+9.89%
18.2M
+81.45%
Retained Earnings
-128.8M
+28.45%
-100.3M
+37.18%
-73.1M
+57.08%
-46.5M
+56.03%
Total Stockholders Equity
23.6M
-30.35%
33.9M
-41.32%
57.8M
-23.22%
75.3M
+32.26%
Total Shares Outstanding
46.2M
+71.29%
26.9M
+7.56%
25.1M
+2.34%
24.5M
+27.69%
Cash Flow
Cash from Operating Activities
-6.4M
+50.97%
-4.2M
-78.59%
-19.8M
+99.91%
-9.9M
+1,553.50%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-799,000
-48.88%
-1.6M
-20.54%
-2.0M
-62.23%
-5.2M
+112.05%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
14.9M
+1,358.67%
1.0M
+264.41%
-621,000
-121.54%
2.9M
-93.35%
Financials Ratio
Gross Margin
55.25%
+12.39%
49.16%
-12.14%
55.95%
-1.35%
56.72%
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-57.90%
+46.80%
-39.44%
+27.20%
-31.01%
+48.88%
-20.83%
N/A
Return on Equity
-105.08%
+77.32%
-59.26%
+48.47%
-39.91%
+57.91%
-25.28%
N/A
Revenue Growth
0.008%
-99.96%
18.65%
+177.51%
6.72%
-17.12%
8.11%
N/A
Current Ratio
2.08
+47.17%
1.41
-50.15%
2.84
-29.88%
4.05
N/A
Cash Ratio
1.18
+177.92%
0.43
-69.56%
1.40
-56.77%
3.23
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow